Celldex Therapeutics Inc
Change company Symbol lookup
Select an option...
CLDX Celldex Therapeutics Inc
NRSN Neurosense Therapeutics Ltd
ACNT Ascent Industries Co
FATH Fathom Digital Manufacturing Corp
PAYX Paychex Inc
WAVD Wavedancer Inc
RNXT RenovoRx Inc
GBNY Generations Bancorp NY Inc
POL Polished.Com Inc
MDGS Medigus Ltd

Health Care : Biotechnology | Small Cap Growth
Company profile

Celldex Therapeutics, Inc. is a biopharmaceutical company. It is focused on developing therapeutic monoclonal and bispecific antibodies that address diseases for which available treatments are inadequate. Its drug candidates include antibody-based therapeutics, which has the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Its Barzolvolimab, a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity, which is studied across multiple mast cell driven diseases, including Chronic Urticarias, Prurigo Nodularis and Eosinophilic Esophagitis. Its bispecific platform includes CDX-585 and CDX-527. CDX-585 combines its active PD-1 blockade and anti-ILT4 blockade to prevent immunosuppressive signals in T cells and myeloid cells, respectively. Its other programs include CDX-1140, a fully human agonist monoclonal antibody targeted to CD40.

The symbol you entered, AVAN, changed to CLDX.

Day's Change
-0.69 (-2.47%)
B/A Size
Day's High
Day's Low

Today's volume of 66,430 shares is on pace to be much lighter than CLDX's 10-day average volume of 422,315 shares.


Upcoming Events

CLDX's fiscal year ends in December
There are no upcoming events for CLDX

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
August 8, 2023Q2 2023 Earnings Release-$0.65-$0.72 to -$0.63-$0.77
May 4, 2023Q1 2023 Earnings Release-$0.62-$0.66 to -$0.60-$0.49
February 28, 2023Q4 2022 Earnings Release-$0.56-$0.61 to -$0.56-$0.43
November 9, 2022Q3 2022 Earnings Release-$0.57-$0.59 to -$0.55-$0.45

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.